Syndax Pharmaceuticals Inc - COM (SNDX)

Historical Portfolio Holders from Q1 2016 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
90.2 M
Holdings value Q1 2024
$2.15 B
Value change Q1 2024
+$41.9 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
184
Number of buys Q1 2024
4
Number of sells Q1 2024
-2
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
87164F105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 46.8 K $963 K +$733 K $20.53 6
2024 Q1 90.2 M $2.15 B +$41.9 M $23.80 186
2023 Q4 88.7 M $1.92 B +$407 M $21.61 177
2023 Q3 71 M $1.03 B -$485 K $14.52 175
2023 Q2 70.6 M $1.48 B -$49.6 M $20.93 163
2023 Q1 73 M $1.54 B +$24.9 M $21.12 160
2022 Q4 71.3 M $1.82 B +$266 M $25.45 155
2022 Q3 59.4 M $1.43 B +$96.9 M $24.03 132
2022 Q2 54.5 M $1.05 B +$13.5 M $19.24 113
2022 Q1 54.3 M $944 M -$34.8 M $17.38 131
2021 Q4 52.2 M $1.14 B +$54.3 M $21.89 128
2021 Q3 48.9 M $935 M -$21.2 M $19.11 120
2021 Q2 50 M $859 M +$12.1 M $17.17 112
2021 Q1 48.5 M $1.08 B +$47.1 M $22.36 130
2020 Q4 46.3 M $1.03 B +$270 M $22.24 139
2020 Q3 34.2 M $505 M +$23.4 M $14.76 96
2020 Q2 32.3 M $479 M +$173 M $14.82 96
2020 Q1 20.7 M $227 M +$45.3 M $10.97 79
2019 Q4 16.7 M $146 M -$3.75 M $8.78 68
2019 Q3 17.1 M $128 M -$885 K $7.47 69
2019 Q2 17.1 M $159 M +$4.61 M $9.31 68
2019 Q1 17 M $89 M +$8.09 M $5.25 67
2018 Q4 15.5 M $68.8 M -$2.73 M $4.45 71
2018 Q3 15.3 M $124 M +$3.41 M $8.08 72
2018 Q2 15.1 M $106 M -$23.3 M $7.02 81
2018 Q1 17.2 M $244 M +$3.4 M $14.23 72
2017 Q4 16 M $140 M +$23 M $8.76 76
2017 Q3 15 M $176 M -$8.29 M $11.70 67
2017 Q2 15.7 M $219 M +$56.8 M $13.97 65
2017 Q1 11.7 M $160 M +$30.2 M $13.72 63
2016 Q4 11.1 M $79.7 M -$4.87 M $7.17 54
2016 Q3 11.6 M $176 M +$19.9 M $15.16 44
2016 Q2 10.3 M $101 M +$10.8 M $9.85 46
2016 Q1 9.44 M $126 M +$126 M $13.32 27